AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2017
Feb 23, 2017
32566_dirs_2017-02-23_ed40b294-45db-4d4c-b7a7-f1c60fafe166.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2017-02-22
Reporting Person: HENDERSON JOHN T (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-22 | Common Stock | P | 2000 | $18.8065 | Acquired | 38524 | Direct |
| 2017-02-23 | Common Stock | P | 3600 | $18.58 | Acquired | 42124 | Direct |
| 2017-02-23 | Common Stock | P | 400 | $18.573 | Acquired | 42524 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 300 | Indirect |
More from MYRIAD GENETICS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 5
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 2